Glimpazin-25 (Empagliflozin 25 mg Tablets):
Product Information
– Brand Name: Glimpazin-25
– Active Ingredient: Empagliflozin
– Strength: 25 mg
– Form: Tablets
Therapeutic Class
– Antidiabetic agent
– SGLT2 inhibitor
Indications
– Treatment of type 2 diabetes mellitus
– Improves glycemic control
– Reduces risk of cardiovascular events
– Adjunct to diet and exercise
Mechanism of Action
– Inhibits sodium-glucose cotransporter 2 (SGLT2)
– Reduces glucose reabsorption in kidneys
– Increases glucose excretion in urine
Benefits
– Effective glycemic control
– Reduced risk of cardiovascular events
– Convenient once-daily dosing
– Weight loss potential
– Improved blood pressure control
Side Effects
– Common:
– Urinary tract infections
– Increased urination
– Thirst
– Headache
– Hypoglycemia (low blood sugar)
– Less common:
– Allergic reactions
– Increased risk of genital mycotic infections
– Increased risk of acute kidney injury
Contraindications
– Hypersensitivity to empagliflozin
– Severe kidney impairment (eGFR <30 mL/min/1.73 m²)
– End-stage renal disease (ESRD)
– Dialysis
– Pregnancy and lactation (caution advised)
Precautions
– Monitor blood sugar, kidney function, and liver enzymes regularly
– Inform doctor about concomitant medications
– Caution in patients with:
– Renal or hepatic impairment
– History of pancreatitis
– History of hypersensitivity reactions
